Macrophages are the dominant effector cells responsible for IgG-mediated passive systemic anaphylaxis challenged by natural protein antigen in BALB/c and C57BL/6 mice.

[1]  F. Finkelman,et al.  Rapid desensitization of mice with anti-FcγRIIb/FcγRIII mAb safely prevents IgG-mediated anaphylaxis. , 2013, The Journal of allergy and clinical immunology.

[2]  Y. Liu,et al.  Characteristics of anaphylaxis‐inducing IgG immune complexes triggering murine passive systemic anaphylaxis , 2013, Allergy.

[3]  Wei Zhao,et al.  Human FcγRIIA induces anaphylactic and allergic reactions. , 2012, Blood.

[4]  H. Watier,et al.  2nd Charles Richet et Jules Héricourt Workshop , 2011, mAbs.

[5]  Takao Shimizu,et al.  Mouse and human neutrophils induce anaphylaxis. , 2011, The Journal of clinical investigation.

[6]  A. Matucci,et al.  Acute infusion reactions induced by monoclonal antibody therapy , 2011, Expert review of clinical immunology.

[7]  H. Karasuyama,et al.  IgG-mediated systemic anaphylaxis to protein antigen can be induced even under conditions of limited amounts of antibody and antigen. , 2010, Biochemical and biophysical research communications.

[8]  A. Matucci,et al.  Anti‐infliximab IgE and non‐IgE antibodies and induction of infusion‐related severe anaphylactic reactions , 2010, Allergy.

[9]  Thomas Singer,et al.  The safety and side effects of monoclonal antibodies , 2010, Nature Reviews Drug Discovery.

[10]  H. Karasuyama,et al.  New insights into the roles for basophils in acute and chronic allergy. , 2009, Allergology international : official journal of the Japanese Society of Allergology.

[11]  Takao Shimizu,et al.  Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. , 2008, Immunity.

[12]  J. Ravetch,et al.  Analyzing antibody-Fc-receptor interactions. , 2008, Methods in molecular biology.

[13]  F. Finkelman.  Anaphylaxis: lessons from mouse models. , 2007, The Journal of allergy and clinical immunology.

[14]  E. Savilahti,et al.  Severe adverse reactions to Infliximab therapy are common in young children with inflammatory bowel disease , 2007, Acta paediatrica.

[15]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[16]  D. Moneret-vautrin,et al.  Epidemiology of life‐threatening and lethal anaphylaxis: a review , 2005, Allergy.

[17]  F. Finkelman,et al.  Molecular mechanisms of anaphylaxis: lessons from studies with murine models. , 2005, The Journal of allergy and clinical immunology.

[18]  W. Vaughan,et al.  Cytotoxicity, DNA cross-linking, and DNA single-strand breaks induced by cyclophosphamide in a rat leukemia in vivo , 2004, Cancer Chemotherapy and Pharmacology.

[19]  F. Finkelman,et al.  Pathways of anaphylaxis in the mouse. , 2002, The Journal of allergy and clinical immunology.

[20]  M. Nagata,et al.  Anti-granulocyte antibody suppression of active and passive anaphylactic shock in WBB6F1-W/Wv mice , 1997, Cellular and Molecular Life Sciences CMLS.

[21]  D. Mccluskey,et al.  Anaphylaxis with intravenous gammaglobulin , 1990, The Lancet.

[22]  H. Laborit,et al.  [Cytotoxicity]. , 2018, Agressologie: revue internationale de physio-biologie et de pharmacologie appliquees aux effets de l'agression.